Body Surface Area May Predict Risk of Psoriatic Arthritis in Patients With Psoriasis

September 22nd 2021, 3:41pm


Greater body surface area was shown to correlate with an increased risk of psoriatic arthritis development in patients with psoriasis, with obesity and depression also identified as risk factors.

Guselkumab Associated With Improved HRQOL, Skin Manifestations in Patients With Psoriasis

September 18th 2021, 2:15pm


Treatment of guselkumab was found to be safe and effective in improving health-related quality-of-life (HRQOL) and skin manifestations of patients with moderate to severe psoriasis in a real-world setting.

High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries

September 15th 2021, 7:15pm


Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.

Alpha-Glucosidase Inhibitor Use in Type 2 Diabetes Linked With Increased Psoriatic Disease Risk

September 11th 2021, 2:00pm


Discontinued use and high dosage of alpha-glucosidase inhibitors in combination with metformin was shown to increase risk of psoriasis and psoriatic arthritis in patients with type 2 diabetes compared with those given only metformin.

Phase 2 Study Finds Tildrakizumab Effective for PsA Manifestations

September 9th 2021, 4:30pm


Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although improvement in symptoms of dactylitis and enthesitis were not observed.

Depression, Lack of Efficacy Linked With DMARD Discontinuation in PsA

September 1st 2021, 9:00pm


By year 5 of therapy with disease-modifying anti-rheumatic drugs (DMARDs), only about one-third of patients with psoriatic arthritis (PsA) were expected to be continuing with their therapy.

Biologic Use May Decrease Risk of Psoriatic Arthritis in Patients With Psoriasis

August 26th 2021, 5:00pm


Patients with psoriasis who received biologic treatments were at significantly lower risk of developing psoriatic arthritis, with women representing a potentially at-risk group.

Physical Activity May Lower Risk of Cardiovascular Disease in Patients With Psoriasis

August 18th 2021, 6:30pm


Physical activity was significantly associated with cardiorespiratory fitness and pulse wave velocity, a preclinical indicator of future cardiovascular disease risk, in patients with psoriasis.

Psoriasis Linked With Severe Coronary Calcification, Heart Disease

August 15th 2021, 4:15pm


A recent study aimed to understand whether psoriasis and psoriatic arthritis are independent risk factors for coronary calcification and coronary artery disease. It found both correlate with higher rates of calcification, but only psoriasis was linked with severe calcification and disease.

Study: Psoriatic Arthritis, Joint Pain Drive Analgesic Use in Patients With Psoriasis

August 10th 2021, 4:19pm


A new prospective cohort study suggests joint pain, rather than skin pain or disease severity, correlates with greater use of analgesics.